ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,852.86
-0.55%
Gold vs US Dollar
2,360.185
0.35%
Brent Oil
84.335
1.80%
Bitcoin
68,240.00
-1.66%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Genetic Technologies Ltd (GENE)

  7. Genetic Technologies Ltd (GENE) News

Genetic Technologies (GENE)

Genetic Technologies Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GENE
DateTimeSourceHeadlineSymbolCompany
28/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
23/05/202413:00GlobeNewswire Inc.GeneType and Humanise Health host “Know Your Risk” EventNASDAQ:GENEGenetic Technologies Ltd
06/05/202413:00GlobeNewswire Inc.GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 million U.S. employeesNASDAQ:GENEGenetic Technologies Ltd
22/04/202420:00GlobeNewswire Inc.Genetic Technologies Announces Closing of US$2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
18/04/202417:17GlobeNewswire Inc.Genetic Technologies Announces $2 Million Registered Direct OfferingNASDAQ:GENEGenetic Technologies Ltd
17/04/202413:00GlobeNewswire Inc.New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment OutcomesNASDAQ:GENEGenetic Technologies Ltd
16/04/202413:00GlobeNewswire Inc.GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on YearNASDAQ:GENEGenetic Technologies Ltd
11/04/202413:00GlobeNewswire Inc.GTG to pilot GeneType in Breast Screen centers across the U.S.NASDAQ:GENEGenetic Technologies Ltd
08/04/202413:00GlobeNewswire Inc.EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”NASDAQ:GENEGenetic Technologies Ltd
02/04/202413:05GlobeNewswire Inc.Genetic Technologies’ Digital Strategy Ignites Significant Traction in US MarketNASDAQ:GENEGenetic Technologies Ltd
26/03/202412:00GlobeNewswire Inc.GTG Global Collaborations and Innovation UpdateNASDAQ:GENEGenetic Technologies Ltd
25/03/202412:00GlobeNewswire Inc.GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised HealthcareNASDAQ:GENEGenetic Technologies Ltd
26/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
15/02/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
14/02/202419:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GENEGenetic Technologies Ltd
31/01/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
31/01/202413:00GlobeNewswire Inc.Launching our most comprehensive test and expanding into new global marketsNASDAQ:GENEGenetic Technologies Ltd
09/01/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
05/01/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
05/01/202413:00GlobeNewswire Inc.Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:GENEGenetic Technologies Ltd
05/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GENEGenetic Technologies Ltd
28/12/202313:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
27/12/202313:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:GENEGenetic Technologies Ltd
20/12/202322:00Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:GENEGenetic Technologies Ltd
14/12/202313:00GlobeNewswire Inc.GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized WellnessNASDAQ:GENEGenetic Technologies Ltd
12/12/202313:00GlobeNewswire Inc.Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio ChangeNASDAQ:GENEGenetic Technologies Ltd
30/10/202312:00GlobeNewswire Inc.Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical TrialNASDAQ:GENEGenetic Technologies Ltd
18/10/202313:30GlobeNewswire Inc.GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and TreatmentNASDAQ:GENEGenetic Technologies Ltd
27/09/202314:00GlobeNewswire Inc.GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital NetworkNASDAQ:GENEGenetic Technologies Ltd
12/09/202313:00GlobeNewswire Inc.Breakthrough: GeneType for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Cleared for Australian ReleaseNASDAQ:GENEGenetic Technologies Ltd
 Showing the most relevant articles for your search:NASDAQ:GENE

Your Recent History

COIN
ZENUSD
Horizen
HITB
ZENETH
Horizen
BIT
I08132
Intesa Sanpaolo
BIT
UV8CNF
UniCredit Bank
MRTX
FCNBTC
FreelancerChain
BIT
P1USK0
NLBNPIT1USK0 20991231 10...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved